Anne Yuqing Yang1, Jong Hun Lee2, Limin Shu3, Chengyue Zhang1, Zheng-Yuan Su3, Yaoping Lu4, Mou-Tuan Huang4, Christina Ramirez5, Douglas Pung6, Ying Huang1, Michael Verzi7, Ronald P Hart8, Ah-Ng Tony Kong9. 1. Center for Cancer Prevention Research, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA; Graduate Program in Pharmaceutical Sciences, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA. 2. Center for Cancer Prevention Research, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA; Department of Food Science and Biotechnology, CHA university, Kyunggi, Korea. 3. Center for Cancer Prevention Research, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA. 4. Center for Cancer Prevention Research, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA; Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA. 5. Department of Pharmaceutics, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA; Graduate Program in Cellular and Molecular Pharmacology, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA. 6. Department of Pharmaceutics, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA. 7. Department of Genetics, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA. 8. Department of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA. 9. Center for Cancer Prevention Research, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA; Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA. Electronic address: kongt@pharmacy.rutgers.edu.
Abstract
AIMS: Ultraviolet irradiation and carcinogens have been reported to induce epigenetic alterations, which potentially contribute to the development of skin cancer. We aimed to study the genome-wide DNA methylation profiles of skin cancers induced by ultraviolet B (UVB) irradiation and 7,12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-1,3-acetate (TPA). MAIN METHODS: Methylated DNA immunoprecipitation (MeDIP) followed by next-generation sequencing was utilized to ascertain the DNA methylation profiles in the following common mouse skin cancer models: SKH-1 mice treated with UVB irradiation and CD-1 mice treated with DMBA/TPA. Ingenuity® Pathway Analysis (IPA) software was utilized to analyze the data and to identify gene interactions among the different pathways. KEY FINDINGS: 6003 genes in the UVB group and 5424 genes in the DMBA/TPA group exhibited a greater than 2-fold change in CpG methylation as mapped by the IPA software. The top canonical pathways identified by IPA after the two treatments were ranked were pathways related to cancer development, cAMP-mediated signaling, G protein-coupled receptor signaling and PTEN signaling associated with UVB treatment, whereas protein kinase A signaling and xenobiotic metabolism signaling were associated with DMBA/TPA treatment. In addition, the mapped IL-6-related inflammatory pathways displayed alterations in the methylation profiles of inflammation-related genes linked to UVB treatment. SIGNIFICANCE: Genes with altered methylation were ranked in the UVB and DMBA/TPA models, and the molecular interaction networks of those genes were identified by the IPA software. The genome-wide DNA methylation profiles of skin cancers induced by UV irradiation or by DMBA/TPA will be useful for future studies on epigenetic gene regulation in skin carcinogenesis.
AIMS: Ultraviolet irradiation and carcinogens have been reported to induce epigenetic alterations, which potentially contribute to the development of skin cancer. We aimed to study the genome-wide DNA methylation profiles of skin cancers induced by ultraviolet B (UVB) irradiation and 7,12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-1,3-acetate (TPA). MAIN METHODS: Methylated DNA immunoprecipitation (MeDIP) followed by next-generation sequencing was utilized to ascertain the DNA methylation profiles in the following common mouseskin cancer models: SKH-1 mice treated with UVB irradiation and CD-1 mice treated with DMBA/TPA. Ingenuity® Pathway Analysis (IPA) software was utilized to analyze the data and to identify gene interactions among the different pathways. KEY FINDINGS: 6003 genes in the UVB group and 5424 genes in the DMBA/TPA group exhibited a greater than 2-fold change in CpG methylation as mapped by the IPA software. The top canonical pathways identified by IPA after the two treatments were ranked were pathways related to cancer development, cAMP-mediated signaling, G protein-coupled receptor signaling and PTEN signaling associated with UVB treatment, whereas protein kinase A signaling and xenobiotic metabolism signaling were associated with DMBA/TPA treatment. In addition, the mapped IL-6-related inflammatory pathways displayed alterations in the methylation profiles of inflammation-related genes linked to UVB treatment. SIGNIFICANCE: Genes with altered methylation were ranked in the UVB and DMBA/TPA models, and the molecular interaction networks of those genes were identified by the IPA software. The genome-wide DNA methylation profiles of skin cancers induced by UV irradiation or by DMBA/TPA will be useful for future studies on epigenetic gene regulation in skin carcinogenesis.
Authors: Stella Tommasi; Reinhard Dammann; Zhongqiu Zhang; Yian Wang; Limin Liu; Walter M Tsark; Sharon P Wilczynski; Jie Li; Ming You; Gerd P Pfeifer Journal: Cancer Res Date: 2005-01-01 Impact factor: 12.701
Authors: K S Chan; S Sano; K Kataoka; E Abel; S Carbajal; L Beltran; J Clifford; M Peavey; J Shen; J Digiovanni Journal: Oncogene Date: 2007-08-13 Impact factor: 9.867
Authors: Neel Sengupta; Christopher Yau; Anuratha Sakthianandeswaren; Dmitri Mouradov; Peter Gibbs; Nirosha Suraweera; Jean-Baptiste Cazier; Guadalupe Polanco-Echeverry; Anil Ghosh; Mohamed Thaha; Shafi Ahmed; Roger Feakins; David Propper; Sina Dorudi; Oliver Sieber; Andrew Silver; Cecilia Lai Journal: Mol Cancer Date: 2013-01-03 Impact factor: 27.401
Authors: Shanyi Li; Yuqing Yang; Davit Sargsyan; Renyi Wu; Ran Yin; Hsiao-Chen Dina Kuo; Irene Yang; Lujing Wang; David Cheng; Christina N Ramirez; Rasika Hudlikar; Yaoping Lu; Ah-Ng Kong Journal: Cancer Prev Res (Phila) Date: 2020-03-11
Authors: Yue Guo; Jong Hun Lee; Limin Shu; Ying Huang; Wenji Li; Chengyue Zhang; Anne Yuqing Yang; Sarandeep Ss Boyanapalli; Ansu Perekatt; Ronald P Hart; Michael Verzi; Ah-Ng Tony Kong Journal: Cell Biosci Date: 2015-05-27 Impact factor: 7.133